Thrombosis of the Renal Vein and Inferior Vena Cava Associated With Placental Fetal Vascular Malperfusion in a Neonate Exposed to Methadone Maintenance Therapy In Utero.

Methadone, an opioid agonist, is the recommended treatment for pregnant women with opioid use disorder (OUD). Fetal/neonatal autopsy findings as well as placental changes in the setting of maternal OUD or methadone maintenance therapy (MMT) are not well-characterized. Here we present a case of a neonate who had exposure to MMT while in utero and died shortly after birth and was subsequently found to have multifocal calcified renal vein thrombosis, a recent inferior vena cava thrombus, and placental features of fetal vascular malperfusion at autopsy.

Comparative expression of cyclooxygenase 2 and Ki67 in amelanotic and conventional oral melanomas.

BACKGROUND: Oral melanomas have some histopathological resemblance with its cutaneous counterpart; however, an aggressive behavior is more common in tumors that occur in the oral cavity. Several markers have been suggested as indicative of tumoral progression and aggressiveness, such as cyclooxygenase 2 (COX-2) and Ki67. MATERIAL AND METHODS: In this study, we have compared the expression of COX-2 and Ki67 in a series of amelanotic (n=7) and melanotic oral melanomas (n=22). The cases were selected from 4 pathology laboratories and submitted to the immunohistochemical (IHC) reactions. We analyzed the IHC staining based on a qualitative - using visual scores; and a computer-assisted method (quantitative) using scanned slides and software for digital analysis. RESULTS: COX-2 was expressed in all oral melanomas; however, its intensity was significantly higher in the amelanotic ones (P<0.001). Similarly, a high Ki67-positivity index was observed in the amelanotic than melanotic ones (P<0.001). CONCLUSIONS: Based on these results, we suggest that amelanotic oral melanomas have marked pro-inflammatory and high-proliferative phenotype, justifying their more aggressive behavior compared with the melanotic ones.

Dental developmental alterations in patients with dilacerated teeth.

BACKGROUND: The aim of this study was to record and analyze all DDAs associated to dilacerated teeth in patients attending the clinics of the Postgraduate Division, Facultad de Odontología, UNAM in Mexico City. MATERIAL AND METHODS: Orthopantomograms from all patients seeking for stomatological attention in our institution were reviewed and those cases of dilaceration were separated. Age, gender, diagnosis, location, involved teeth and associated DDAs were recorded and analyzed. RESULTS: From 6,340 patients, 99 (1.6%) harbored 125 dilacerated teeth. Of them, 45 (45.5%) showed one or more DDAs. The most frequently detected DDAs were hypodontia, enamel pearls, taurodontism and microdontia. CONCLUSIONS: 45.5% is a very high proportion of DDAs in patients with dilacerated roots. Findings from this study strongly suggest that patients with dilacerated teeth should be carefully screened since many of them could present other DDAs. Simultaneous occurrence of dilaceration and DDAs suggests synchronic developmental defects during dental growth.

STUDY OF THE EVALUATION PROCESS OF CLASS II DEVICES IN THE UNITED STATES AND THE RELATION WITH THE ORIGIN AND PREPARATION OF THE MANUFACTURERS / ESTUDIO DEL PROCESO DE EVALUACIÓN DE DISPOSITIVOS DE CLASE II EN LOS ESTADOS UNIDOS Y LA RELACIÓN CON EL ORIGEN Y LA PREPARACIÓN DE LOS FABRICANTES / ESTUDO DO PROCESSO DE AVALIAÇÃO DE DISPOSITIVOS DE CLASSE II NOS ESTADOS UNIDOS E DA RELAÇÃO COM A ORIGEM E DESENVOLVIMENTO DE FABRICANTES

The global production of medical devices has increased due to growth in developing countries, hence the evaluation of pre marketing medical devices is needed to provide safety for patients and operators of such technology. In the US evaluation of medical devices is done before marketing depending on the type of device to be introduced. To market Class II devices the developer must present the application 510 (k) by which a study of "approval" of the new device is made to an existing one. However, many producers from different countries take more time to fulfill the requirements of the study indicating that they might not be fully prepared. This article aims to return the number of devices, the duration of study time and device manufacturer's countries applying the study to know the countries that are best prepared in assessing their technology. A database of the FDA was used to establish the countries applying the test 510 (k). A hierarchical classification of countries by discriminating variables as the average length of study and number of studies requested by each country was used. Three groups of countries which are discriminated according to the study duration and the number of devices presented were classified. The first group contains countries that had large amounts of equipment evaluation and had short duration of the study period. Such countries are traditionally recognized as strong producing countries of medical devices. The second group is contrary to the first, countries that submitted few devices and the duration of the study was higher indicating that they are not well prepared for technology assessment. The third group presents variability in the amount of devices presented; however the duration of the study is relatively constant for all countries in this group, which can be classified as developing countries for the production of medical devices. It is necessary to strengthen the production of Class II medical devices in Latin America. The duration of the studies evaluating devices is a great source of information to predict the best prepared countries when assessing their technology manufacturers.

La producción mundial de dispositivos médicos ha aumentado debido al crecimiento en los países en desarrollo, por lo tanto, es necesaria la evaluación de los productos sanitarios previos al ingresar al mercadeo para proporcionar seguridad a los pacientes y a los operadores de este tipo de tecnología. En los EEUU la evaluación de dispositivos médicos se hace antes de la comercialización en función del tipo de dispositivo a ser introducido. Para la comercialización de dispositivos de Clase II el promotor debe presentar la solicitud 510 (k) por la que se hace un estudio de "aprobación" del nuevo dispositivo a uno ya existente. Sin embargo, muchos productores de diferentes países toman más tiempo para cumplir con los requisitos del estudio indicando que no están preparados por completo. Este artículo tiene como objetivo analizar el número de dispositivos devueltos, la duración del tiempo de estudio y los países del fabricante del dispositivo que aplican al estudio para conocer los países que están mejor preparados para evaluar su tecnología. Se utilizó una base de datos de la FDA para establecer los países que aplican la prueba de 510 (k). Se utilizó una clasificación jerárquica de los países discriminando variables como la duración media de estudio y el número de estudios solicitados por cada país. Tres grupos de países fueron clasificados divididos de acuerdo a la duración del estudio y el número de dispositivos presentados. El primer grupo contiene países que tenían grandes cantidades de evaluación de equipos y tuvieron corta duración en el período de estudio. Esos países son tradicionalmente reconocidos como países productores fuertes de dispositivos médicos. El segundo grupo es contrario al primero, los países que presentaron dispositivos y la duración del estudio fue mayor, lo que indica que no están bien preparados para la evaluación de la tecnología. El tercer grupo presenta una variabilidad en la cantidad de dispositivos presentados, sin embargo, la duración del estudio es relativamente constante para todos los países de este grupo, que pueden ser calificados como los países en desarrollo para la producción de dispositivos médicos. Es necesario fortalecer la producción de dispositivos médicos de Clase II en América Latina. La duración de los estudios de evaluación de dispositivos es una gran fuente de información para predecir los países mejor preparados en la evaluación de sus fabricantes de tecnología.

A produção mundial de dispositivos médicos tem aumentado devido ao crescimento nos países em desenvolvimento, portanto, a avaliação de dispositivos médicos antes da comercialização é necessário para garantir a segurança para pacientes e operadores deste tipo de tecnologia. Nos EEUU a avaliação do dispositivo médico é feito antes da comercialização de acordo com o tipo de dispositivo a ser introduzido. Para a comercialização de dispositivos de Classe II o promotor deve apresentar a solicitação 510 (k) com a qual se faz um estudo de "aprovação" do novo dispositivo a um já existente. No entanto, muitos produtores de diferentes países levam mais tempo para cumprir os requisitos do estudo indicando que eles não estão completamente despreparados. Este artigo tem por objetivo analisar o número de dispositivos devolvidos, a duração do tempo do estudo e os países do fabricante do dispositivo que aplicam o estudo para determinar os países que estão em melhores condições para avaliar a sua tecnologia. Um banco de dados do FDA foi usado para estabelecer os países que aplicam o teste de 510 (k). Foi utilizada uma classificação hierárquica dos países que discriminam variáveis, tais como a duração média de estudo e número de estudos solicitados por cada país. Três grupos de países foram classificados divididos de acordo com a duração do estudo e o número de dispositivos apresentados. O primeiro grupo composto por países com grandes quantidades de avaliação de equipamentos e que tiveram uma curta duração no período de estudo. Estes países são tradicionalmente reconhecidos como fortes países produtores de dispositivos médicos. O segundo grupo é contrário ao primeiro, os países que apresentaram os dispositivos e da duração do estudo foi maior, indicando que eles não estão bem preparados para a avaliação da tecnológica. O terceiro grupo apresenta uma variabilidade do número de dispositivos apresentados, no entanto, a duração do estudo é relativamente constante para todos os países neste grupo, podem ser classificados como países em desenvolvimento, para a produção de dispositivos médicos. É necessário reforçar a produção de dispositivos médicos da classe II na América Latina. A duração dos estudos de avaliação de dispositivos é uma grande fonte de informação para prever o melhor preparado para avaliar fornecedores de tecnologia.

In vitro effect of sodium fluoride on antioxidative enzymes and apoptosis during murine odontogenesis.

Excessive fluoride ingestion has been identified as a risk factor for fluorosis and oxidative stress. The oxidative stress results from the loss of equilibrium between oxidative and antioxidative mechanisms that can produce kinase activation, mitochondrial disturbance and DNA fragmentation, resulting in apoptosis. Actually many people are exposed to no-adverted fluoride consumption in acute or chronic way. The aim of this study was to determine the effect of sodium fluoride on first molar germ in relation to its effect on antioxidative enzymes immunoexpression and apoptosis. Thirty first molar germs from 1-day-old Balb/c mice were cultured for 24 h with sodium fluoride (0 mM, 1 mM and 5 mM). Immunoexpression determination of CuZnSod, MnSod, catalase, Bax, Bid, caspase 8, caspase 9, caspase 3 and TUNEL assay were performed. Cellular disorganization in ameloblast and odontoblast-papilla zones was observed. CuZnSod and MnSod immunoexpression decrease in experimental groups. Caspase 8, caspase 3, Bax, Bid increase expression and more TUNEL positive cells in both experimental groups than control, suggest that apoptosis induced by fluoride is related to oxidative stress due to reduction of the enzymatic antioxidant.

Identification and Pathogenicity of Lasiodiplodia theobromae and Diplodia seriata, the Causal Agents of Bot Canker Disease of Grapevines in Mexico.

Perennial cankers and consequent grapevine dieback are a major problem in vineyards of Sonora and Baja California, the most important grape-production areas of Mexico. In order to identify the canker-causing agents, symptomatic arms, cordons, and trunks were collected from 13 and 6 vineyards in Sonora and Baja California, respectively. Two Botryosphaeriaceae spp., Lasiodiplodia theobromae and Diplodia seriata, were isolated frequently from infected wood and identified based on morphological and cultural characters as well as analyses of nucleotide sequences of three genes, the internal transcribed spacer region (ITS1-5.8S-ITS2), a partial sequence of the ß-tubulin gene, and part of the translation elongation factor 1-α gene (EF1-α). Although both L. theobromae and D. seriata were isolated from grapevine cankers in Baja California, only L. theobromae was found in vines in the Sonora region. Pathogenicity of both species was verified by inoculation of rooted cuttings and green shoots of Thompson Seedless and Chardonnay cultivars. Isolates of L. theobromae were more virulent, based on the extent of spread in the secondary wood and green tissue, than those of D. seriata. These findings confirm L. theobromae and D. seriata as the causal agents of dieback and canker formation of grapevines in northern Mexico.

Two Distinct Isolates of Tomato yellow leaf curl virus Threaten Tomato Production in Arizona and Sonora, Mexico.

Severe yellow leaf curl and plant stunting symptoms were observed in tomato plants from two home gardens in central Arizona (Phoenix area) and a tomato field in Sonora, Mexico during the fall of 2006. Disease symptoms were reminiscent of those reported in Florida during 1994 (4) and more recently in tomato fields in the Pacific Coast state of Sinaloa, Mexico found to be infected with the exotic Tomato yellow leaf curl virus (TYLCV) (2). Total DNA was extracted from two symptomatic tomato plants from Arizona and Sonora and used as a template in PCR. PCR products of the core region of the begomovirus coat protein gene (Cp) were cloned (n = 3) and the DNA sequence was determined. BLAST analysis of the 579 bases with sequences available in the NCBI GenBank database indicated the closest match was to an isolate of the monopartite begomovirus TYLCV from Israel, which was known to have been introduced into the Caribbean region, including Puerto Rico, the southeastern United States, and Mexico from 1990 to 1996 (1,4). The full-length TYLCV genome (approximately 2,800 bases) was amplified for a field isolate from each location by rolling circle amplification (RCA) using TempliPhi (Amersham Biosciences, Piscataway, NJ). RCA products were cloned into the plasmid vector pGEM7 (Promega, Madison, WI) that had been previously digested with SacI endonuclease. The complete TYLCV genome sequence was determined for six clones from each RCA product. Nucleotide analysis indicated that the complete TYLCV genome sequences from Sonora and Arizona, respectively, shared 97.6 and 97.7% nt identity. The comparative sequence analysis indicated that TYLCV-Sonora (TYLCV-Son) (GenBank Accession No. EF210555) was 99.1% nt identical to TYLCV reported recently from Culiacan, Mexico (GenBank Accession No. DQ631892). In contrast, TYLCV-AZ (GenBank Accession No. EF210554) shared 99.3% identity with an isolate from Texas, TYLCV-TX (GenBank Accession No. EF110890) (3). Interestingly, the TX and AZ TYLCV isolates contained a unique 29-nt deletion in the intergenic region (IR) between the TATA-box and the nonanucleotide, initiating at nt coordinate 2696. Except for the deletion in the IR region of the AZ and TX isolates, these viruses shared 97.6 to 99.1% nt identity to other TYLCV isolates reported in the Western Hemisphere. The genome sequence for TYLCV-Son shares high nt identity with TYLCV isolates identified in the Yucatan Peninsula and Pacific Coast of Mexico (2), the Caribbean region, and the southeastern United States, suggesting that a single TYLCV species was introduced and has spread throughout North America and the Caribbean (4). The absence of other TYLCV isolates in the Western Hemisphere with the novel 29-nt deletion noted for the TX and AZ isolates suggests that the latter two isolates originated from the same U.S. source. In Mexico, TYLCV was first introduced in the east coast and Yucatan region approximately in 1996. From there, this isolate has spread to the western part of the country (Sinaloa and Sonora) from 2004 to 2006 (2). Similarly, in the United States, TYLCV was introduced and spread in the eastern U.S. states beginning in 1994 (4), where it had been confined until it was discovered in Texas (3) and now Arizona during 2006. References: (1) J. Bird et al. Plant Dis. 85:1028, 2001. (2) J. K. Brown and A. M. Idris. Plant Dis. 90:1360, 2006. (3) T. Isakeit et al. Plant Dis. 91:466, 2007. (4) J. E. Polston et al. Plant Dis. 78:831, 1994.

Widespread Outbreak of Cucurbit yellow stunting disorder virus in Melon, Squash, and Watermelon Crops in the Sonoran Desert of Arizona and Sonora, Mexico.

Bright yellow, interveinal chlorosis was observed for the first time on leaves of the older and mid-growth of cucurbit plants in southern Arizona and Sonora (Mexico) during September and October of 2006. Some cultivars exhibited substantial yield losses of 30 to 80%. In Arizona, symptoms were in Cucumis melo (muskmelon and honeydew melon) fields in the Yuma Valley and Hyder. In Sonora, honeydew and muskmelon, Cucurbita pepo (acorn, spaghetti, and summer [yellow and zucchini] squash), and Citrullus lanatus (watermelon) were symptomatic in Hermosillo, whereas, in Caborca, honeydew and cantaloupe developed similar symptoms. Interveinal chlorosis was observed in 60 to 100% of the plants in each field. Crops planted mid-to-late season were 100% infected, whereas, the early-season fields experienced approximately 60 to 80% incidence. All symptomatic fields in the Sonoran Desert and vicinity were infested by the whitefly Bemisia tabaci (Genn.), which was identified as the 'B biotype' on the basis of mitochondria COI sequence analysis (data not shown). Whitefly population levels were variable and ranged from 5 to 200 per plant. Total RNA was isolated from leaf samples collected from symptomatic plants using Tri Reagent (Molecular Research Center, Cincinnati, OH). Purified RNA was used in reverse transcriptase-PCR with primers specific to the Cucurbit yellow stunting disorder virus (CYSDV) coat protein (CP) gene (RNA2-deoxyribonucleotide coordinates 4927-4950 and 5657-5679) for the suspected whitefly-transmitted bipartite CYSDV (4). PCR yielded the CYSDV CP fragment, at 753 bp (GenBank Accession Nos. EF21058 and EF21059), which was cloned into pGEM T-Easy and sequenced in both directions using universal primers. The CYSDV CP nucleotide sequences (n = 16) obtained from acorn squash, honeydew melon, muskmelon, yellow squash, and watermelon had 99 to 100% identity. The Arizona (AZ) and Sonora (SON) CYSDV CP sequences shared 99 to 100% identity with previously described CYSDV isolates from the Eastern Hemisphere (GenBank Accession Nos. DQ903105 and DQ903108) and also with two isolates of CYSDV collected during 2004 from Zacapa Valley, Guatemala (GenBank Accession Nos. EF21060 and EF21061) (J. K. Brown, unpublished data). CYSDV is a member of the genus Crinivirus, family Closteroviridae. CYSDV was first identified in cucumber and melon crops in the Middle East approximately 15 years ago and 10 years ago in Spain (1). Most recently, this virus was introduced into Texas (2), Guatemala (J. K. Brown, unpublished data), and Arizona and California (3). CYSDV has therefore emerged as an important and potentially worldwide threat to the production of cultivated cucurbits (3). The threat appears to be significant in light of the introduction or establishment of the exotic B. tabaci biotypes B and Q vectors, which also originated in the Middle Eastern-North African-Mediterranean region. To our knowledge, this is the first report of CYSDV infecting field-grown C. pepo (four types) and watermelon, reported previously only as experimental laboratory hosts, and of CYSDV in two types of melon (C. melo) in Mexico. References: (1) A. Celix et al. Phytopathology 86:1370, 1996. (2) J. Kao et al. Plant Dis. 84:101, 2000. (3) Y.-W. Kuo et al. Plant Dis. 91:330, 2007. (4) L. Rubio et al. J. Gen. Virol. 82:929, 2001.

Fluoride content in bottled waters, juices and carbonated soft drinks in Mexico City, Mexico.

OBJECTIVE: The objective of this study was to analyse 283 samples of soft drinks available in the metropolitan market of Mexico City, Mexico: 105 juices, 101 nectars, 57 carbonated drinks and 20 bottled waters. MATERIALS AND METHODS: Samples of the beverages were analysed using an Orion 720A potentiometer and an Orion 9609BN F ion-specific electrode. RESULTS: Fluoride concentration in the above-mentioned products ranged from 0.07 to 1.42 p.p.m. It was found that fluoride concentrations varied according to the brand, flavour and presentation of the product. The highest mean concentration of fluoride was found in the juices and cola drinks (0.67 +/- 0.38 and 0.49 +/- 0.41 p.p.m., respectively). The mean fluoride concentration for carbonated drinks was 0.43 +/- 0.36 p.p.m. Bottled waters had a fluoride concentration of 0.21 +/- 0.08 p.p.m. CONCLUSIONS: The findings suggest that fluoride ingested through bottled drinks represents an important part of the total fluoride ingested by the population. In view of the wide variation of fluoride concentration in the tested products, it is necessary to implement regulatory guidelines for controlling its concentration in order to prevent dental fluorosis.

Lead levels in primary teeth of children living in Mexico City.

OBJECTIVE: The aim of this study was to discover the lead concentration in primary teeth extracted in the peripheral clinics of the Faculty of Dentistry, UNAM (Mexico City). DESIGN: One hundred healthy primary teeth were collected from 2 to 13-year-old children (52 girls and 48 boys). Sixty-six were maxillary teeth and 34 were mandibular teeth. Lead concentrations were measured by Graphite Furnace Atomic Absorption Spectrophotometry. RESULTS: Our results indicate that lead concentration in the 10-13-year-old group (7.7 micro g/g(-1)) was higher than in the other groups. Geometric mean lead concentration was higher in girls than in boys (7.3 micro g/g(-1) and 6.3 micro g/g(-1), respectively). Maxillary teeth had higher lead concentrations than mandibular teeth and primary canines showed the highest mean lead concentration followed by incisors and molars. Teeth from children living in the south-east area (which according to the Mexico City's Pollution Center data is the more polluted area), presented the highest lead concentration but no statistically significant difference was found among teeth from the different areas. CONCLUSIONS: Our results suggest that age, gender and place of residence are not related to the lead concentration in human primary teeth. This fact seems to indicate the ubiquitous presence of lead in the whole atmosphere of Mexico City and suggests that zones of residence do not appear to influence tooth lead concentration.

Ultrastructure of dental enamel afflicted with hypoplasia: an atomic force microscopic study.

The ultrastructure of the human tooth enamel from a patient diagnosed with hypoplasia (HYP) was investigated using atomic force microscopy (AFM) and compared with the surface of normal human tooth enamel. Hypoplasia is a hereditary defect of dental enamel in which the enamel is deficient in either quality or quantity. AFM results presented for the HYP tooth enamel clearly demonstrate that the apatite crystal morphology in hypoplasia tooth enamel is perturbed in the diseased state which could result from a defective synthesis of the extracellular matrix proteins, e.g., amelogenin, by the ameloblasts. HYP enamel consisting of loosely packed, very small grains does not present a tendency for association, as in the case of the normal healthy tooth. Indeed, the enamel surface affected by HYP is porous and is made of much smaller grains. In some samples, the HYP part of enamel surface appeared in the form of a point-defect, which we believe may be associated with the early stages of the HYP deformation.

Clinico-pathologic study of odontogenic cysts in a Mexican sample population.

BACKGROUND: Odontogenic cysts are uncommon lesions that frequently behave agressively and attain a large size. Unfortunately, information on the relative incidence of these cysts from different populations is not abundant. In Mexico, for example, only a few examples have been reported. The aim of this study was to ascertain the frequency of odontogenic cysts in a Mexican sample and to compare these data with previously reported studies from other countries. METHODS: The files of the Oral and Maxillofacial Pathology Diagnosis Service at the School of Dentistry at the Universidad Nacional Autónoma de México (UNAM) were reviewed and all accessions of odontogenic cysts were listed. Clinical and radiographic data were recorded and microscopic slides evaluated according to the most recent World Health Organization (WHO) classification (1992). RESULTS: Three hundred and four cases of odontogenic cysts (55.9% male predominance) were found. The most frequent odontogenic cysts were the following: periapical cyst (38. 8%); dentigerous cyst (35.5%), and odontogenic keratocyst (18.8%). Periapical cyst was more frequent in females, and maxillary anterior teeth were most commonly involved. Dentigerous cysts appeared in males at a rate of 64.8%, this cyst found more frequently between the 1st and 2nd decades of life and in the molar zone. Odontogenic keratocyst was more frequent in males (59.6%), between the 2nd and 4th decades of life and more common in the molar zone. CONCLUSIONS: More than 50% of the sample were aggressive cysts (dentigerous and keratocyst). Our results suggest that Mexican patients develop aggressive odontogenic cysts more commonly than other populations. Our figures point to the need for a precise diagnosis in order to institute the correct surgical procedure, prevent recurrence, and forestall more extensive tissue destruction.

[Fluorosis in primary dentition in a region with endemic water fluoride]. / Fluorosis en dentición temporal en un área con hidrofluorosis endémica.

OBJECTIVE: The aim of the present study was to estimate the prevalence of dental fluorosis in primary dentition of a San Luis Potosi children population, and its association to fluoride concentration in drinking water and urine. An additional objective was, to develop, validate, and test a specific index for dental fluorosis in primary dentition. MATERIAL AND METHODS: From May 1997, to January 1999, we conducted a cross-sectional study to assess the prevalence of dental fluorosis in primary dentition. Study subjects were 100 children aged 3-6 years, selected at random from three kindergartens in three risk areas of San Luis Potosi. The specific index of dental fluorosis for primary dentition (Dental Fluorosis for Primary Dentition Index--DFPDI) was validated by estimating fluoride concentrations in enamel of teeth with and without dental fluorosis. The Kruskal-Wallis test was used to assess the association between fluoride concentrations in drinking water and urine, with dental fluorosis; the association between risk area and dental fluorosis was assessed with the Mantel-Haenszel chi 2 test. RESULTS: The prevalence of dental fluorosis in primary dentition was 78%; primary molars were most affected in both maxillae and the predominant color was a non-glossy white appearance. We found a strong direct correlation (r = 0.93) between fluoride concentrations in primary teeth and the DFPDI. Associations were found between fluoride concentrations of drinking water and urine, with dental fluorosis (Kruskal-Wallis p = 0.00001), and between risk area and dental fluorosis (Mantel-Haenszel chi 2 p = 0.00001). CONCLUSIONS: DFPDI allowed adequate identification and grading of dental fluorosis in primary dentition. It is important to detect the initial toxic effects of fluoride exposure to predict dental fluorosis in permanent dentition and skeletal fluorosis.

[Bottled beverages as additional sources of exposure to fluoride]. / Bebidas embotelladas como fuentes adicionales de exposición a flúor.

OBJECTIVE: To evaluate and to report the concentration of floride in soft drinks and juices consumed in San Luis Potosi, S.L.P., Mexico, and its implications as a risk factor for developing dental fluorosis. MATERIAL AND METHODS: The contents of some products from 2 main national companies and 2 other local companies were studied. The samples were collected from 10 different batches in the case of the soft drinks, and from 5 batches in the case of the juices, with 3 samples per batch, during 3 months. The ion selective electrode method was used to determine the concentration of fluoride. RESULTS: Soft drinks from 2 main national companies showed high fluoride concentrations that were statistically significant between groups (p < 0.05). Fluoride levels of products from local and national companies also showed differences that were statistically significant between groups (p < 0.05). All natural juices tested showed high fluoride concentrations. CONCLUSIONS: Most soft drinks and juices consumed in SLP had high fluoride levels above Mexican regulations (0.7 ppm) and could be a substantial risk factor for developing dental fluorosis.

Gingival salivary gland choristoma. A case report.

Gingival salivary gland choristoma is an extremely rare disturbance of glandular development. A review of the literature disclosed only 5 reported cases of this entity and 7 gingival salivary gland tumors or alterations. We present a case of this condition present in a 43-year-old female patient, which was found while reviewing casts for the design of a prosthetic appliance. This case suggests that embryonal pluripotentiality of gingival epithelial cells is retained and that development of salivary glands in gingival tissue is feasible. An additional discussion about its histogenesis is presented.

Effects of maternal ethanol intake on second alcoholic generation murine skull and mandibular size.

BACKGROUND: Fetal Alcohol Syndrome (FAS) represents an important array of abnormalities in the development of offspring born of alcoholic mothers. This investigation used a murine Balb/cJ model to investigate the effects of maternal ethanol intake on craniomandibular and long bone development. METHODS: Experimental 8-week-old female mice (daughters of alcoholic female mice) drank an ethanol solution increasing from 1-20%, and 6 weeks later were mated with non-alcoholic males. The control group consisted of normal Balb/cJ male and female mice that drank water without ethanol. Alcohol intake was suspended at delivery, and 90 puppies (second alcoholic generation) were sacrificed at 14.5, 21.5 and 28.5 postnatal days. Measurements of craniofacial structures and long bones were done blindly by means of a standardized method. RESULTS: Our results indicate that maternal ethanol intake had a significant deleterious effect on craniofacial development, since litters from alcoholic mothers had smaller dimensions compared with non-alcoholic control puppies. No statistically significant results were obtained from long bone measurements. CONCLUSIONS: Even though the mechanism that accounts for these changes is not fully explained by our results, we hypothesize that the reduction of cephalometric dimensions found in this study could be a manifestation of disorganized neural and mesenchymal development.

Immunoexpression of epidermal growth factor in odontogenesis of the offspring of alcoholic mice.

Several forms of cell perturbation have been associated with ethanol ingestion. Fetal alcohol syndrome (FAS) as well as diminished maxillofacial development and inhibition of cell regeneration in vitro and in vivo have been described. Epidermal growth factor (EGF) stimulates maxillofacial growth, DNA synthesis, and it is a potent mitogen for a number of various cell types. EGF exerts its effects on cells through binding to a specific cell surface receptor which leads to activation of a thyrosine kinase in the intracellular part of the receptor. The inhibitory effect of alcohol on EGF in the mouse dental follicle was studied in the offspring of alcoholic mothers using immunocytochemistry. Adult female mice were given 22% alcohol in their drinking water and fed a pelleted diet before and during pregnancy. Maternal blood alcohol levels were 262 +/- 1.3 mg/100 ml on gestation day 12.5. The offspring of the alcoholic and control mice were sacrificed on postnatal day 1.5, their mandibles were dissected, weighed and processed by routine immunocytochemistry with the following results. 1) Significant differences were found in mandible weight p < 0.01 after parturition. 2) The tooth germs in the offspring of ethanol treated mice were morphometrically smaller than those of control littermates. 3) Immunoexpression of EGF in the mandibular first molar of the control group was strong and homogeneous while in the experimental group the expression was light and heterogeneous. It is concluded that maternal alcoholism reduces EGF in the offspring.